MiMedx Group Inc (MDXG)
9.22
+0.16
(+1.77%)
USD |
NASDAQ |
Nov 21, 16:00
9.215
0.00 (0.00%)
After-Hours: 20:00
MiMedx Group Debt to Equity Ratio: 0.1051 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.1051 |
| June 30, 2024 | 0.1146 |
| March 31, 2024 | 0.1249 |
| December 31, 2023 | 0.337 |
| September 30, 2023 | 36.82 |
| June 30, 2023 | -3.856 |
| March 31, 2023 | -2.714 |
| December 31, 2022 | -2.702 |
| September 30, 2022 | -2.483 |
| June 30, 2022 | -3.555 |
| March 31, 2022 | -6.489 |
| December 31, 2021 | 586.91 |
| September 30, 2021 | -8.267 |
| June 30, 2021 | -6.712 |
| March 31, 2021 | -5.937 |
| December 31, 2020 | -317.98 |
| September 30, 2020 | 3.701 |
| June 30, 2020 | 2.853 |
| March 31, 2020 | 2.155 |
| December 31, 2019 | 1.909 |
| September 30, 2019 | 1.666 |
| June 30, 2019 | 2.707 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 |
| Date | Value |
|---|---|
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.00 |
| December 31, 2012 | 0.2005 |
| September 30, 2012 | 0.2433 |
| June 30, 2012 | 0.3374 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-317.98
Minimum
Dec 2020
586.91
Maximum
Dec 2021
13.72
Average
-1.189
Median
Debt to Equity Ratio Benchmarks
| CEL-SCI Corp | -- |
| AIM ImmunoTech Inc | 0.9382 |
| IGC Pharma Inc | 0.0183 |
| NovaBay Pharmaceuticals Inc | 0.0476 |
| Protalix BioTherapeutics Inc | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 243.89M |
| Total Liabilities (Quarterly) | 62.88M |
| Shareholders Equity (Quarterly) | 181.01M |
| Current Ratio | 4.104 |
| Net Debt Paydown Yield | 0.69% |